Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|
SNP | N cases/sub-cohort | IRRab | CI (95%)c | Pd | N cases/sub-cohort | IRRab | CI (95%)c | Pd | |
ERCC1 Asn118Asn | TT | 84/177 | 1e | * | 84/156 | 1e | * | ||
CT | 100/193 | 1.04 | 0.72–1.50 | 0.66 | 66/156 | 0.78 | 0.51–1.19 | 0.48 | |
CC | 34/61 | 1.13 | 0.66–1.94 | 27/52 | 0.90 | 0.50–1.63 | |||
missing | 3/11 | 7/4 | |||||||
ASE-1 G-21A | GG | 152/299 | 1e | * | 124/248 | 1e | * | ||
AG | 60/124 | 0.94 | 0.64–1.38 | 0.73 | 45/106 | 0.85 | 0.55–1.32 | 0.96 | |
AA | 7/10 | 2.11 | 0.71–6.21 | 9/11 | 1.58 | 0.60–4.18 | |||
missing | 2/9 | 6/3 | |||||||
RAI IVS1 A4364G | AA | 156/280 | 1e | * | 107/230 | 1e | * | ||
AG | 56/138 | 0.69 | 0.47–1.03 | 0.13 | 61/124 | 1.17 | 0.77–1.80 | 0.20 | |
GG | 6/13 | 0.89 | 0.31–2.57 | 8/10 | 1.95 | 0.71–5.33 | |||
missing | 3/11 | ||||||||
High risk haplotype | No | 165/319 | 1e | * | 125/280 | 1e | * | ||
Yesf | 53/110 | 1.01 | 0.68–1.51 | 51/82 | 1.35 | 0.84–2.16 | |||
missing | 3/13 | 8/6 |